AbbVie Inc. — Director's Dealing 2021

Dec 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-12-20

Reporting Person: Durkin Brian L (VP, Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-20	Common Stock, $0.01 par value	M	7180	$61.36	Acquired	28295	Direct
2021-12-20	Common Stock, $0.01 par value	S	11790	$128.51	Disposed	16505	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-20	Option (right to buy)	$0	M	7180	Disposed	2027-02-15	Common Stock (7180)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.